ArticleCase reports in gastroenterology

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment.

Taketo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.